Global Cell & Gene Therapy Cold Chain Logistics Markets Report 2022: Rapidly Growing Clinical Trials and FDA Approvals Toward Authorizing Cell and Gene Therapy
April 06, 2022 04:03 ET
|
Research and Markets
Dublin, April 06, 2022 (GLOBE NEWSWIRE) -- The "Global Cell & Gene Therapy Cold Chain Logistics Market, By Component, By Services Offered, By Mode of Transportation, By Holding Temperature...
Nurix Therapeutics Doses First Patient in Phase 1 Clinical Trial of DeTIL-0255, a Drug-Enhanced Cell Therapy for the Treatment of Patients with Solid Tumors
April 05, 2022 07:00 ET
|
Nurix Therapeutics, Inc.
SAN FRANCISCO, April 05, 2022 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs, today announced...
$22.49 Billion Worldwide Cell Culture Industry to 2031 - Identify Growth Segments for Investment
April 05, 2022 05:23 ET
|
Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Cell Culture Global Market Report 2022: By Type, By Media, By Applications" report has been added to ResearchAndMarkets.com's offering. This report...
Global $33+ Billion CAR-T Cell Therapy Markets, 2017-2021 & 2022-2027: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma
April 05, 2022 04:33 ET
|
Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market, By Product Type, By Tumor Type, By Indication, By Treatment Type, By Targeted Antigen, By End User, By Region,...
Neurona Therapeutics to Present at the Locust Walk Stem Cell Tx Conference
April 04, 2022 16:01 ET
|
Neurona Therapeutics
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies to treat chronic neurological disorders, today...
Tessa Therapeutics Appoints Wilson W. Cheung as Chief Financial Officer
April 04, 2022 06:00 ET
|
Tessa Therapeutics Ltd
SINGAPORE, April 04, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and...
Global Automated and Closed Cell Therapy Processing Systems Market was valued at USD 694.92 million in 2021 and projected to grow at a CAGR of 25.18% during the forecast period 2022-2028 : GreyViews
April 02, 2022 16:30 ET
|
GreyViews
Pune, India, April 02, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences
March 29, 2022 10:56 ET
|
Cytovia Therapeutics
AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...
Bone Therapeutics réoriente sa stratégie autour du développement d’ALLOB, son produit de thérapie cellulaire phare
March 29, 2022 01:00 ET
|
Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Réorientation stratégique afin de concentrer les efforts de Bone Therapeutics sur l’obtention des principaux résultats de l’étude de Phase IIb évaluant ALLOB dans...
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
March 29, 2022 01:00 ET
|
Bone Therapeutics SA
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB Phase IIb study in tibial fractures. Discussions for ALLOB global partnership...